A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Neurochem Inc.

About Neurochem Inc.

Neurochem's strategic plan focuses on the further development of a strong, steadily expanding pipeline of product candidates addressing vital unmet medical needs. These products focus primarily on neurological diseases.

With promising drug candidates currently in clinical trials for AA Amyloidosis, Alzheimer's disease, and hemorrhagic stroke due to cerebral amyloid angiopathy, and with expanding drug development programs for other research projects,




AA Amyloidosis: Fibrillex™


Alzhemed™ --Alzheimer's Disease --inhibit the amyloid cascade :

Level of Action:

--prevent and stop the formation and deposition of amyloid fibrils in the brain by binding to soluble Aß prior to fibril formation;

--to favor the clearance of soluble Aß from the brain, lowering the risk of fibril formation

--to inhibit the inflammatory response associated with amyloid build-up in Alzheimer's disease.


Cerebril™ --Hemorrhagic stroke due to cerebral amyloid angiopathy:


More Info on Neurochem Corp


Home Page for Neurochem

Key Statistics for Neurochem

Basic Chart for Neurochem

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.